Results 21 to 30 of about 6,215,751 (161)

Recognition and epileptology of protracted CLN3 disease. [PDF]

open access: yesEpilepsia, 2023
AbstractObjectiveThis study was undertaken to analyze phenotypic features of a cohort of patients with protracted CLN3 disease to improve recognition of the disorder.MethodsWe analyzed phenotypic data of 10 patients from six families with protracted CLN3 disease.
Cameron JM   +10 more
europepmc   +4 more sources

Osmotic stress changes the expression and subcellular localization of the Batten disease protein CLN3. [PDF]

open access: yesPLoS ONE, 2013
Juvenile CLN3 disease (formerly known as juvenile neuronal ceroid lipofuscinosis) is a fatal childhood neurodegenerative disorder caused by mutations in the CLN3 gene.
Amanda Getty   +6 more
doaj   +2 more sources

Loss of Cln3 function in the social amoeba Dictyostelium discoideum causes pleiotropic effects that are rescued by human CLN3. [PDF]

open access: yesPLoS ONE, 2014
The neuronal ceroid lipofuscinoses (NCL) are a group of inherited, severe neurodegenerative disorders also known as Batten disease. Juvenile NCL (JNCL) is caused by recessive loss-of-function mutations in CLN3, which encodes a transmembrane protein that ...
Robert J Huber   +2 more
doaj   +2 more sources

A diagnostic confidence scheme for CLN3 disease. [PDF]

open access: yesJ Inherit Metab Dis, 2021
AbstractOver the past 20 years, diagnostic testing for genetic diseases has evolved, leading to variable diagnostic certainty for individuals included in long‐term natural history studies. Using genotype and phenotype data from an ongoing natural history study of CLN3 disease, we developed a hierarchical diagnostic confidence scheme with three major ...
Masten MC   +8 more
europepmc   +3 more sources

Brain proton MR spectroscopy measurements in CLN3 disease. [PDF]

open access: yesMol Genet Metab, 2023
CLN3 is an autosomal recessive lysosomal disorder with intracellular accumulation of ceroid-lipofuscins. CLN3 classically has onset around 4-6 years of age involving vision loss, followed by developmental regression and seizures. Symptoms are progressive and result in premature death.
Dang Do AN   +5 more
europepmc   +3 more sources

The parent and family impact of CLN3 disease: an observational survey-based study. [PDF]

open access: yesOrphanet J Rare Dis
Background CLN3 disease (also known as CLN3 Batten disease or Juvenile Neuronal Ceroid Lipofuscinosis) is a rare pediatric neurodegenerative disorder caused by biallelic mutations in CLN3.
Schulz A   +5 more
europepmc   +3 more sources

Loss of the lysosomal protein CLN3 triggers c-Abl-dependent YAP1 pro-apoptotic signaling [PDF]

open access: yesEMBO Reports
Batten disease is characterized by early-onset blindness, juvenile dementia and death within the second decade of life. The most common genetic cause are mutations in CLN3, encoding a lysosomal protein.
Neuza Domingues   +13 more
doaj   +5 more sources

The CLN3 Disease Staging System: A new tool for clinical research in Batten disease. [PDF]

open access: yesNeurology, 2020
To develop a disease-specific staging system for CLN3 disease and to test the hypothesis that salient and discrete clinical features of CLN3 disease may be used to define disease stages by analyzed data from an 18-year-long natural history study.A proposed staging system, the CLN3 Staging System (CLN3SS), was based on salient and clinically meaningful ...
Masten MC   +8 more
europepmc   +4 more sources

The Effect of CLN3 Disease on Organellar Characteristics [PDF]

open access: yes, 2021
CLN3 disease, or juvenile dementia, is a lysosomal storage disorder with largely neurological symptoms. Towards the end of their lives, individuals with CLN3 disease develop a cardiac phenotype, which has not yet been systematically studied. On a cellular level, mutations in CLN3 have been shown to disrupt the endo-lysosomal system.
Coode, Emily
openaire   +2 more sources

Global network analysis in Schizosaccharomyces pombe reveals three distinct consequences of the common 1-kb deletion causing juvenile CLN3 disease. [PDF]

open access: yesSci Rep, 2021
Juvenile CLN3 disease is a recessively inherited paediatric neurodegenerative disorder, with most patients homozygous for a 1-kb intragenic deletion in CLN3. The btn1 gene is the Schizosaccharomyces pombe orthologue of CLN3.
Minnis CJ   +6 more
europepmc   +5 more sources

Home - About - Disclaimer - Privacy